These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1515414)

  • 21. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells.
    Newman MJ; Lane EA; Nugent MA; Racker E
    Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor production by chemically transformed cells.
    Moses HL; Branum EL; Proper JA; Robinson RA
    Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell division is required for expression of v-myc transforming properties in chicken embryonic neuroretina cells.
    Bechade C; Calothy G
    Oncogene; 1991 Dec; 6(12):2311-7. PubMed ID: 1662792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines.
    Ciardiello F; Sanfilippo B; Yanagihara K; Kim N; Tortora G; Bassin RH; Kidwell WR; Salomon DS
    Cancer Res; 1988 May; 48(9):2483-91. PubMed ID: 2833347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transformation-restoring factor: a low molecular weight secreted factor required for anchorage-independent growth of oncogene-resistant mutant cell lines.
    Yang JJ; Kang JS; Krauss RS
    Oncogene; 1995 Apr; 10(7):1291-9. PubMed ID: 7731679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor (EGF) receptor density controls mitogenic activation of normal rat kidney (NRK) cells by EGF.
    Lahaye DH; Camps MG; Erp PE; Peters PH; Zoelen EJ
    J Cell Physiol; 1998 Jan; 174(1):9-17. PubMed ID: 9397151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of transforming growth factor beta on the anchorage-independent growth of murine epithelial JB6 cells.
    Wilder PJ; Rizzino A
    Cancer Res; 1991 Nov; 51(21):5898-902. PubMed ID: 1933858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle.
    Stampfer MR; Pan CH; Hosoda J; Bartholomew J; Mendelsohn J; Yaswen P
    Exp Cell Res; 1993 Sep; 208(1):175-88. PubMed ID: 7689475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
    Sonobe MH; Bravo R; Armelin MS
    Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of the expression of transforming growth factor-beta s 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells.
    Danielpour D; Kim KY; Winokur TS; Sporn MB
    J Cell Physiol; 1991 Aug; 148(2):235-44. PubMed ID: 1880152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ; Dickson RB
    Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial characterization of the mitogenic action of pp60v-src, the oncogenic protein product of the src gene of avian sarcoma virus.
    Durkin JP; Whitfield JF
    J Cell Physiol; 1984 Aug; 120(2):135-45. PubMed ID: 6086674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T.
    Valverius EM; Ciardiello F; Heldin NE; Blondel B; Merlo G; Smith G; Stampfer MR; Lippman ME; Dickson RB; Salomon DS
    J Cell Physiol; 1990 Nov; 145(2):207-16. PubMed ID: 2174061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of transforming growth factors by simian sarcoma virus-transformed cells.
    van Zoelen EJ; van Rooijen MA; van Oostwaard TM; de Laat SW
    Cancer Res; 1987 Mar; 47(6):1582-7. PubMed ID: 3028611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.
    Münger K; Pietenpol JA; Pittelkow MR; Holt JT; Moses HL
    Cell Growth Differ; 1992 May; 3(5):291-8. PubMed ID: 1633111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
    Yamada Y; Serrero G
    J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resumption of cell cycle in BALB/c-3T3 fibroblasts arrested by polyamine depletion: relation with "competence" gene expression.
    Charollais RH; Mester J
    J Cell Physiol; 1988 Dec; 137(3):559-64. PubMed ID: 3142887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.